The Lundquist Institute
Indu Kannan is an experienced medical professional currently serving as an Attending Physician at Harbor-UCLA Medical Center and an Investigator at The Lundquist Institute for Biomedical Innovation, both since October 2021. Additionally, Indu holds the position of Assistant Clinical Professor at the David Geffen School of Medicine at UCLA since May 2019. A healthcare consultant since February 2017, Indu has previously worked as an Attending Physician at Olive View - UCLA Medical Center and as a Senior Healthcare Consultant at Cedars-Sinai from June 2017 to March 2019. Earlier experience includes roles as a Physician at Kaiser Permanente and Children's Hospital Los Angeles, as well as training as a Resident Physician at NYU Langone Medical Center. Indu holds a Doctor of Medicine (M.D.) from Chicago Medical School at Rosalind Franklin University of Medicine and Science and a Master’s Degree in Biomedical Sciences from the same institution.
This person is not in any teams
The Lundquist Institute
The Lundquist Institute, formerly the Los Angeles Biomedical Research Institute (LA BioMed), is an engine of innovation with a global reach and a 67-year reputation of improving and saving lives. With its new medical research building, its state-of-the-art incubator, “BioLabs at The Lundquist,” existing laboratory and support infrastructure, and a 15-acre tech park in the planning stages, The Lundquist Institute is poised to serve as a hub for the Los Angeles area’s burgeoning biotech scene. The research institute has over 100 principal investigators (PhDs, MDs, and MD/PhDs) working on more than 600 research studies, including therapies for numerous orphan diseases, and is responsible for three FDA-approved drugs including the first approved treatment for sickle cell disease in 20 years.